πŸ‡ΊπŸ‡Έ FDA
Patent

US 6846908

DCR-5 bone affecting ligand

expired A61KA61K38/00A61P

Quick answer

US patent 6846908 (DCR-5 bone affecting ligand) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jan 25 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61P, A61P19/08